205 related articles for article (PubMed ID: 37307224)
1. The impact of common pharmaceutical excipients on the gut microbiota.
Subramaniam S; Kamath S; Ariaee A; Prestidge C; Joyce P
Expert Opin Drug Deliv; 2023; 20(10):1297-1314. PubMed ID: 37307224
[TBL] [Abstract][Full Text] [Related]
2. Targeting the gut microbiome to control drug pharmacomicrobiomics: the next frontier in oral drug delivery.
Kamath S; Stringer AM; Prestidge CA; Joyce P
Expert Opin Drug Deliv; 2023; 20(10):1315-1331. PubMed ID: 37405390
[TBL] [Abstract][Full Text] [Related]
3. The Effects of Pharmaceutical Excipients on Gastrointestinal Tract Metabolic Enzymes and Transporters-an Update.
Zhang W; Li Y; Zou P; Wu M; Zhang Z; Zhang T
AAPS J; 2016 Jul; 18(4):830-43. PubMed ID: 27184579
[TBL] [Abstract][Full Text] [Related]
4. An Overview of Pharmaceutical Excipients: Safe or Not Safe?
Abrantes CG; Duarte D; Reis CP
J Pharm Sci; 2016 Jul; 105(7):2019-26. PubMed ID: 27262205
[TBL] [Abstract][Full Text] [Related]
5. Drug pharmacomicrobiomics and toxicomicrobiomics: from scattered reports to systematic studies of drug-microbiome interactions.
Aziz RK; Hegazy SM; Yasser R; Rizkallah MR; ElRakaiby MT
Expert Opin Drug Metab Toxicol; 2018 Oct; 14(10):1043-1055. PubMed ID: 30269615
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiota-drug interactions in cancer pharmacotherapies: implications for efficacy and adverse effects.
Leigh SJ; Lynch CMK; Bird BRH; Griffin BT; Cryan JF; Clarke G
Expert Opin Drug Metab Toxicol; 2022 Jan; 18(1):5-26. PubMed ID: 35176217
[TBL] [Abstract][Full Text] [Related]
7. Excipient Stability in Oral Solid Dosage Forms: A Review.
Darji MA; Lalge RM; Marathe SP; Mulay TD; Fatima T; Alshammari A; Lee HK; Repka MA; Narasimha Murthy S
AAPS PharmSciTech; 2018 Jan; 19(1):12-26. PubMed ID: 28895106
[TBL] [Abstract][Full Text] [Related]
8. Impact Of Excipient Variability On Drug Product Processing And Performance.
Peng Soh JL; Liew CV; Sia Heng PW
Curr Pharm Des; 2015; 21(40):5890-9. PubMed ID: 26446469
[TBL] [Abstract][Full Text] [Related]
9. Safety of surfactant excipients in oral drug formulations.
Maher S; Geoghegan C; Brayden DJ
Adv Drug Deliv Rev; 2023 Nov; 202():115086. PubMed ID: 37739041
[TBL] [Abstract][Full Text] [Related]
10. Bringing pharmacomicrobiomics to the clinic through well-designed studies.
Steiner HE; Patterson HK; Giles JB; Karnes JH
Clin Transl Sci; 2022 Oct; 15(10):2303-2315. PubMed ID: 35899413
[TBL] [Abstract][Full Text] [Related]
11. Lipid excipients and delivery systems for pharmaceutical development: a regulatory perspective.
Chen ML
Adv Drug Deliv Rev; 2008 Mar; 60(6):768-77. PubMed ID: 18077051
[TBL] [Abstract][Full Text] [Related]
12. Interaction between drugs and the gut microbiome.
Weersma RK; Zhernakova A; Fu J
Gut; 2020 Aug; 69(8):1510-1519. PubMed ID: 32409589
[TBL] [Abstract][Full Text] [Related]
13. Gut microbiota: what is its place in pharmacology?
Tarasiuk A; Fichna J
Expert Rev Clin Pharmacol; 2019 Oct; 12(10):921-930. PubMed ID: 31544557
[No Abstract] [Full Text] [Related]
14. Reactive impurities in excipients: profiling, identification and mitigation of drug-excipient incompatibility.
Wu Y; Levons J; Narang AS; Raghavan K; Rao VM
AAPS PharmSciTech; 2011 Dec; 12(4):1248-63. PubMed ID: 21948318
[TBL] [Abstract][Full Text] [Related]
15. Polyoxylglycerides and glycerides: effects of manufacturing parameters on API stability, excipient functionality and processing.
Jannin V; Rodier JD; Musakhanian J
Int J Pharm; 2014 May; 466(1-2):109-21. PubMed ID: 24607211
[TBL] [Abstract][Full Text] [Related]
16. A comprehensive review on pharmaceutical excipients.
Pockle RD; Masareddy RS; Patil AS; Patil PD
Ther Deliv; 2023 Jul; 14(7):443-458. PubMed ID: 37464784
[TBL] [Abstract][Full Text] [Related]
17. Applications of Polymers as Pharmaceutical Excipients in Solid Oral Dosage Forms.
Debotton N; Dahan A
Med Res Rev; 2017 Jan; 37(1):52-97. PubMed ID: 27502146
[TBL] [Abstract][Full Text] [Related]
18. Particle Engineering of Excipients for Direct Compression: Understanding the Role of Material Properties.
Mangal S; Meiser F; Morton D; Larson I
Curr Pharm Des; 2015; 21(40):5877-89. PubMed ID: 26446468
[TBL] [Abstract][Full Text] [Related]
19. The effects of excipients on transporter mediated absorption.
Goole J; Lindley DJ; Roth W; Carl SM; Amighi K; Kauffmann JM; Knipp GT
Int J Pharm; 2010 Jun; 393(1-2):17-31. PubMed ID: 20417699
[TBL] [Abstract][Full Text] [Related]
20. Gut microbiome interactions with drug metabolism, efficacy, and toxicity.
Wilson ID; Nicholson JK
Transl Res; 2017 Jan; 179():204-222. PubMed ID: 27591027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
